TRIB3 and acute promyelocytic leukemia: Our study revealed that TRIB3 induced by ATRA/arsenic therapy further inhibits PPARγ activity to dysregulate TG and adipocytokine secretion in APL cells, which subsequently contributes to the disordered lipid metabolism associated with APL.